Aspire Biopharma Holdings Inc. (NASDAQ:ASBP) operates through its wholly owned subsidiary, Buzz Bomb Caffeine Company. Buzz Bomb Caffeine Company markets BUZZ BOMB™, a proprietary sublingual caffeine supplement designed for rapid absorption and convenience. The subsidiary recently launched a redesigned website and updated product branding, and is set to showcase its flagship product at The Sports & Active Nutrition Summit USA in San Diego.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1133832) on February 05, 2026, and is solely responsible for the information contained therein.
Comments